Company profile
Ticker
ARLZ
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Aralez Pharmaceuticals Inc.
SEC CIK
Corporate docs
Latest filings (excl ownership)
8-K
Departure of Directors or Certain Officers
30 May 19
8-K
Other Events
13 May 19
8-K
Completion of Acquisition or Disposition of Assets
7 Mar 19
8-K
Other Events
6 Feb 19
8-K
Departure of Directors or Certain Officers
18 Jan 19
8-K
Entry into a Material Definitive Agreement
12 Dec 18
8-K
Other Events
2 Nov 18
8-K
Other Events
5 Oct 18
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
1 Oct 18
25-NSE
Exchange delisting
27 Sep 18
Latest ownership filings
SC 13G/A
Aralez Pharmaceuticals Inc.
25 Jun 18
4
ANDREW I KOVEN
6 Jun 18
4
ANDREW I KOVEN
16 May 18
4
James Patrick Tursi
16 May 18
4
ANDREW I KOVEN
21 Mar 18
4
Eric Trachtenberg
21 Mar 18
4
Mark A Glickman
21 Mar 18
4
James Patrick Tursi
21 Mar 18
4
Michael Kaseta
19 Mar 18
SC 13G/A
Aralez Pharmaceuticals Inc.
14 Feb 18
Institutional ownership, Q2 2022
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 1 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 509.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Captrust Financial Advisors | 509.00 | $0.00 |